Published on Dec 20, 2024
MAC is pleased to participate in The 2024 Subaru Share the Love@ Event!As part of a national partnership with Meals on Wheels America, Subaru of America, Inc. and its retailers […]
Do Common Acid Reflux Medicines Increase Dementia Risk?
A recent study published in the journal Neurology suggests a potential association between long-term use of proton pump inhibitors (PPIs), commonly taken to treat heartburn and acid reflux, and an increased risk of dementia. The study focused on individuals aged 45 to 64 and found that those who took PPIs for over four years had a 33% higher risk of developing dementia compared to those who never used these drugs. It’s important to note that the study establishes an association, not a direct causal link, and further research is needed for confirmation.
The research, involving 5,712 participants without dementia at the study’s start, revealed that out of 1,500 individuals who took PPIs during the study period, 58 developed dementia. The study considered factors such as age, sex, race, and health conditions in its analysis. However, limitations include participants reporting medication use only once a year, potentially leading to inaccuracies, and the exclusion of over-the-counter medications from the study.
Possible links between PPIs and dementia include B12 deficiency and impaired amyloid metabolism. Low B12 levels have been associated with impaired thinking and poor memory, but the study lacked B12 data for participants. Experts also suggest a potential connection between PPIs and alterations in brain enzymes that clear a protein called amyloid, a key component in Alzheimer’s disease.
For individuals taking PPIs for more than four years, the study recommends consulting with a doctor about alternative options, as abruptly stopping these medications may worsen symptoms. Alternatives include over-the-counter antacids and H2 blockers. Lifestyle changes, such as dietary adjustments and weight loss, can also help manage acid reflux.
The study underscores the importance of patients discussing their medications, including over-the-counter ones, with healthcare professionals to make informed decisions about their treatment plans. It highlights the need for further research to validate the findings and explore the potential link between PPI use and dementia.
Past Stories
Published on Dec 19, 2024
Parkinson’s Disease (PD) is a neurodegenerative disorder that affects dopamine-producing neurons in the brain, leading to symptoms such as tremors, stiffness, and difficulty with movement. While there is no cure […]
Published on Dec 18, 2024
It’s the most wonderful time of the year! Spaghetti Dinner time! Tickets are on sale now for out 2025 Spaghetti Dinner fundraiser. CLICK HERE for more info!
